American Society of Echocardiography (ASE) & EACVI Clinical Reference Guide 2026

 ADULT TRANSTHORACIC ECHOCARDIOGRAPHY GUIDELINES

American Society of Echocardiography (ASE) & EACVI Clinical Reference Guide

This clinical reference handbook compiles the complete standard quantification criteria, normal reference intervals, hemodynamic cutoffs, and diagnostic grading algorithms from the American Society of Echocardiography (ASE) and European Association of Cardiovascular Imaging (EACVI). Formatted specifically for daily clinic use, point-of-care reference, and advanced cardiology examination preparation.

1. LEFT VENTRICLE (LV) QUANTIFICATION

A. LV Linear Dimensions & Wall Thickness (2D / 2D-guided M-mode)

Linear dimensions should be measured perpendicular to the LV long axis at or immediately below the mitral leaflet tips at end-diastole (onset of QRS) and end-systole (smallest cavity dimension / aortic valve closure).

Parameter	Male Reference (Mean ± SD)	Male Normal Range	Female Reference (Mean ± SD)	Female Normal Range
LVIDd (mm)	50.2 ± 4.1	42.0 – 58.4 mm	45.0 ± 3.6	37.8 – 52.2 mm
LVIDd Indexed (mm/m²)	25.0 ± 2.5	22.0 – 30.0 mm/m²	26.0 ± 2.6	23.0 – 31.0 mm/m²
LVIDs (mm)	32.4 ± 3.7	25.0 – 39.8 mm	28.2 ± 3.3	21.6 – 34.8 mm
LVIDs Indexed (mm/m²)	17.0 ± 2.3	13.0 – 21.0 mm/m²	17.0 ± 2.2	13.0 – 21.0 mm/m²
Septal Thickness (IVSd) (mm)	9.0 ± 1.0	6.0 – 10.0 mm	8.0 ± 1.0	6.0 – 9.0 mm
Posterior Wall (LVPWd) (mm)	9.0 ± 1.0	6.0 – 10.0 mm	8.0 ± 1.0	6.0 – 9.0 mm
Relative Wall Thickness (RWT)	0.36 ± 0.05	≤ 0.42	0.36 ± 0.05	≤ 0.42

B. LV Mass, Relative Wall Thickness (RWT), and Geometry Classification

Formulas:

• LV Mass (ASE Cube / Devereux formula) = 0.8 × 1.04 × [(IVSd + LVIDd + LVPWd)³ – (LVIDd)³] + 0.6 g

• Relative Wall Thickness (RWT) = (2 × LVPWd) / LVIDd

• LV Mass Index (LVMI) = LV Mass / Body Surface Area (BSA)

LV Mass / Geometry Category	Men (g/m²)	Women (g/m²)	RWT Cutoff	Geometric Definition
Normal Geometry	≤ 115 g/m²	≤ 95 g/m²	≤ 0.42	Normal LV Mass Index and Normal RWT
Concentric Remodeling	≤ 115 g/m²	≤ 95 g/m²	> 0.42	Normal LV Mass Index with Increased RWT
Eccentric Hypertrophy	> 115 g/m²	> 95 g/m²	≤ 0.42	Increased LV Mass Index with Normal RWT
Concentric Hypertrophy	> 115 g/m²	> 95 g/m²	> 0.42	Increased LV Mass Index with Increased RWT
Severe LV Hypertrophy	≥ 149 g/m²	≥ 122 g/m²	Any	Definitive severe structural hypertrophy

C. LV Volumes and Ejection Fraction (Biplane Simpson's Method of Discs)

Biplane method of discs (modified Simpson's rule) in apical 4- and 2-chamber views is the recommended standard. When 2 or more contiguous LV endocardial segments are poorly visualized, intravenous ultrasound enhancing agents (contrast) are recommended.

LV Parameter	Normal Range (Men)	Normal Range (Women)	Mildly Abnormal	Moderately Abnormal	Severely Abnormal
EDV Indexed (mL/m²)	34 – 74 mL/m²	29 – 61 mL/m²	75 – 89 (M) / 62 – 70 (F)	90 – 100 (M) / 71 – 80 (F)	> 100 (M) / > 80 (F)
ESV Indexed (mL/m²)	11 – 31 mL/m²	8 – 24 mL/m²	32 – 38 (M) / 25 – 32 (F)	39 – 45 (M) / 33 – 40 (F)	> 45 (M) / > 40 (F)
LVEF (%)	52 – 72 %	54 – 74 %	41 – 51 %	30 – 40 %	< 30 %

D. Global Longitudinal Strain (GLS) by 2D Speckle-Tracking

• Normal Cutoff: Normal Adult Range: Approximately -20% ± 2% (Values more negative than -20% are normal).

• Abnormal Cutoff: Values less negative than -18% indicate subclinical or borderline LV systolic dysfunction; values less negative than -16% are definitively abnormal.

• Key Clinical Patterns: Cardiac amyloidosis (relative apical sparing pattern: apical strain / [basal + mid strain] > 1.0); cardiotoxicity surveillance in chemotherapy (relative reduction > 15% from baseline warrants oncocardiology evaluation); subclinical dysfunction in severe aortic stenosis with preserved EF.

OBESITY PEARL: Always report LV mass indexed to BSA. In obese individuals (BMI ≥ 30 kg/m²), indexing to height^2.7 (cutoffs: > 48 g/m^2.7 for men, > 45 g/m^2.7 for women) prevents underestimation of left ventricular hypertrophy.

2. LEFT VENTRICULAR DIASTOLIC FUNCTION EVALUATION

Evaluation is performed according to the ASE/EACVI 2016 Diastolic Guidelines algorithm, dividing patients into two distinct pathways: (1) Normal LVEF without known myocardial disease, and (2) Depressed LVEF or Normal LVEF with known structural/myocardial disease.

A. Step 1: In Patients with Normal LVEF (Determine Presence vs Absence of Dysfunction)

Evaluate the 4 primary criteria:

• 1. E/e' Ratio: Average E/e' ratio > 14 (or Septal E/e' > 15, Lateral E/e' > 13)

• 2. Annular e' Velocity: Septal e' velocity < 7 cm/s OR Lateral e' velocity < 10 cm/s

• 3. Peak TR Velocity: TR Peak Velocity > 2.8 m/s (using Continuous-Wave Doppler)

• 4. LA Enlargement: LA Volume Index (LAVI) > 34 mL/m²

Positive Criteria Count	Diastolic Function Diagnosis	Clinical Action / Interpretation
< 50% Positive (< 2 of 4)	Normal LV Diastolic Function	Normal LV filling pressures and normal myocardial relaxation.
> 50% Positive (≥ 3 of 4)	LV Diastolic Dysfunction Present	Proceed to Grading Algorithm to determine filling pressures.
Exactly 50% Positive (2 of 4)	Indeterminate	Cannot definitively classify; correlate with clinical findings or use ancillary tools.

B. Step 2: Grading Diastolic Dysfunction (Patients with Depressed EF or Myocardial Disease)

Initiate analysis with the transmitral inflow pattern (PW Doppler at mitral leaflet tips):

• Pattern 1 (Low Filling): E/A ratio ≤ 0.8 AND Peak E velocity ≤ 50 cm/s: Grade I Diastolic Dysfunction (Impaired relaxation with NORMAL left atrial pressure / LAP).

• Pattern 2 (Restrictive): E/A ratio ≥ 2.0 (with E deceleration time usually < 160 ms): Grade III Diastolic Dysfunction (Restrictive filling pattern with MARKEDLY ELEVATED LAP).

• Pattern 3 (Intermediate Zone): E/A ratio ≤ 0.8 with Peak E > 50 cm/s, OR E/A ratio > 0.8 and < 2.0: Evaluate the 3 criteria below to distinguish Grade I from Grade II:

Evaluated Criteria in Intermediate Zone	Abnormal / Elevated Cutoff	Clinical Purpose
1. Average E/e' ratio	> 14	Reflects elevated mean left atrial pressure.
2. Peak TR velocity	> 2.8 m/s	Reflects elevated pulmonary artery systolic pressure secondary to LAP.
3. LA Volume Index (LAVI)	> 34 mL/m²	Chronic structural remodeling marker of prolonged elevated LAP.

Grade of Diastolic Dysfunction	E/A Ratio	Average E/e'	Peak TR Velocity	LAVI	Estimated LAP / LVEDP
Normal	0.8 – 2.0	< 10	< 2.8 m/s	≤ 34 mL/m²	Normal LAP
Grade I (Impaired Relaxation)	≤ 0.8 (E ≤ 50 cm/s) or <2 criteria (+)	< 10 – 14	< 2.8 m/s	Normal or >34 mL/m²	Normal LAP (elevated only with exercise)
Grade II (Pseudonormal)	0.8 – 2.0 (≥2 of 3 criteria +)	> 14	> 2.8 m/s	> 34 mL/m²	Elevated LAP
Grade III (Restrictive)	≥ 2.0 (DT < 160 ms)	> 14	> 2.8 m/s	> 34 mL/m²	Markedly Elevated LAP

C. Secondary & Ancillary Diastolic Parameters

• Valsalva Manoeuvre: A decrease in mitral E/A ratio ≥ 0.5 during the strain phase indicates reversible pseudonormalization and unmasks elevated LAP (Grade II).

• Pulmonary Venous Flow: Systolic blunting (S < D velocity) indicates elevated LAP. An pulmonary venous atrial reversal duration exceeding mitral A duration (Ar duration – A duration ≥ 30 ms) strongly indicates elevated LV end-diastolic pressure (LVEDP).

• Diastolic Stress Echocardiography: Indications: Unexplained dyspnea with normal resting diastolic parameters. Positive if: Average E/e' > 14 (or septal > 15), TR peak velocity > 3.4 m/s, and septal e' < 7 cm/s during exercise.

ATRIAL FIBRILLATION DIASTOLOGY PEARL: In atrial fibrillation, mitral A wave and E/A ratio cannot be utilized. Instead, rely on: (1) Peak TR velocity > 2.8 m/s, (2) Septal E/e' > 11 or average E/e' > 14, (3) Mitral E-wave deceleration time ≤ 160 ms, and (4) Isovolumic relaxation time (IVRT) ≤ 65 ms.

3. RIGHT VENTRICLE (RV) QUANTIFICATION

Measurements of RV dimensions must be performed on a dedicated RV-focused apical 4-chamber view at end-diastole. A comprehensive RV assessment requires reporting both linear dimensions and at least one robust measure of systolic function.

A. RV Dimensions & Wall Thickness

RV Measurement Parameter	Anatomic View	Reference Upper Normal Limit	Significance / Clinical Implication
Basal RV Diameter (RVD1)	RV-focused Apical 4Ch	≤ 41 mm	Measured at the maximal basal third; > 41 mm defines RV dilation.
Mid-cavity RV Diameter (RVD2)	RV-focused Apical 4Ch	≤ 35 mm	Measured at the level of LV papillary muscles; > 35 mm indicates dilation.
Longitudinal RV Dimension (RVD3)	RV-focused Apical 4Ch	≤ 83 mm	Measured from tricuspid annular plane to RV apex; > 83 mm indicates dilation.
RVOT Proximal (PLAX)	Parasternal Long-Axis	≤ 35 mm	Anterior RV wall to aortic valve root junction.
RVOT Distal (PSAX)	Parasternal Short-Axis	≤ 27 mm	Measured just proximal to pulmonic valve leaflets.
RV Free Wall Thickness	Subcostal 4-Chamber View	≤ 5.0 mm	Measured at end-diastole excluding trabeculae/epicardial fat; > 5 mm = RV Hypertrophy.

B. Normal Values for Parameters of RV Systolic Function

RV Systolic Parameter	Measurement Technique	Normal Reference Value	Abnormal Cutoff	Key Limitations
TAPSE	M-mode at lateral tricuspid annulus	≥ 17 mm (mean ~24 mm)	< 17 mm	Angle-dependent; load-dependent; less valid post-cardiac surgery.
Pulsed Tissue Doppler S' wave	TDI at lateral tricuspid annulus	≥ 9.5 cm/s (mean ~15 cm/s)	< 9.5 cm/s	Angle-dependent; assumes basal motion reflects global function.
RV Fractional Area Change (FAC)	2D RV apical tracing: (EDA - ESA)/EDA	≥ 35 %	< 35 %	Requires clear definition of heavily trabeculated RV apex.
RV Myocardial Performance Index (RIMP)	PW Doppler [(IVRT + IVCT)/ET]	≤ 0.43	> 0.43	Dependent on loading conditions and rhythm regularities.
Tissue Doppler RIMP	TDI lateral annulus [(IVRT + IVCT)/ET]	≤ 0.54	> 0.54	Acquired from single cycle; higher normal threshold than PW.
3D RV Ejection Fraction (3D RVEF)	3D full-volume reconstruction	≥ 45 %	< 45 %	Dependent on image quality and full RV inclusion.
RV Free Wall Longitudinal Strain	2D speckle-tracking (apical RV)	≤ -20 % (more negative)	> -20 % (e.g. -15%)	Software-dependent; angle-independent; sensitive to subclinical strain reduction.

POST-OPERATIVE RV ASSESSMENT: Post-cardiac surgery (CABG, valve replacement), longitudinal RV parameters (TAPSE and S') frequently decrease without a true reduction in RV global ejection fraction due to geometric alteration. In these patients, RV FAC and 3D RVEF provide superior assessment of actual RV systolic performance.

4. LEFT ATRIUM (LA) QUANTIFICATION

LA size is an established biomarker of chronic LV filling pressures and cardiovascular adverse events. The biplane method of disks (Simpson's method) or biplane area-length method at end-systole (maximum volume immediately before mitral valve opening) indexed to BSA is the recommended standard.

LA Parameter / Severity Grade	Men Reference	Women Reference	Indexed Value (mL/m²)	Clinical Relevance
LA Anteroposterior Diameter (PLAX)	30 – 40 mm	27 – 38 mm	15 – 23 mm/m²	Linear 1D measurement; may underestimate asymmetric LA dilation.
Normal LA Volume Index (LAVI)	16 – 34 mL/m²	16 – 34 mL/m²	16 – 34 mL/m²	Standard physiological volume.
Mild LA Enlargement	35 – 41 mL/m²	35 – 41 mL/m²	35 – 41 mL/m²	Early diastolic dysfunction marker.
Moderate LA Enlargement	42 – 48 mL/m²	42 – 48 mL/m²	42 – 48 mL/m²	Persistent elevated LAP or chronic mitral valve disease.
Severe LA Enlargement	> 48 mL/m²	> 48 mL/m²	> 48 mL/m²	High stroke / AF risk, advanced diastolic failure.

LA Speckle-Tracking Strain (Contemporary ASE Consensus)

• LA Reservoir Strain: LA Reservoir Strain (Peak Atrial Longitudinal Strain / PALS): Normal reference ≥ 35%. Strain < 24-30% indicates impaired compliance, elevated LAP, and correlates with HFpEF hospitalizations and recurrence of atrial fibrillation post-ablation.

5. RIGHT ATRIUM (RA) & INFERIOR VENA CAVA (IVC)

The RA is measured at end-systole in the standard apical 4-chamber view. IVC diameter and collapse index are measured 1.0 to 2.0 cm from the junction with the right atrium in the subcostal view.

A. RA 2D Dimensions & Volume

RA Parameter	Men Reference Range	Women Reference Range	Upper Normal Limit	Measurement Landmark
RA Minor Axis Diameter	≤ 44 mm	≤ 44 mm	44 mm	Mid-atrial transverse line perpendicular to major axis.
RA Major Axis Diameter	≤ 53 mm	≤ 53 mm	53 mm	Distance from tricuspid annulus plane to superior wall.
RA 2D Area	≤ 18 cm²	≤ 18 cm²	18 cm²	End-systolic planimetry excluding IVC/SVC.
RA 2D Volume Index	25 ± 7 mL/m²	21 ± 6 mL/m²	≤ 25 – 29 mL/m²	Single-plane or biplane disk summation at end-systole.

B. IVC Assessment and Right Atrial Pressure (RAP) Estimation

IVC Diameter	Inspiratory Collapsibility (Sniff Test)	Estimated RAP (mmHg)	RAP Range (mmHg)	Clinical State
≤ 2.1 cm	> 50 % collapse	3 mmHg	0 – 5 mmHg	Normal / Low Right Atrial Pressure
> 2.1 cm	< 50 % collapse	15 mmHg	10 – 20 mmHg	High Right Atrial Pressure (Systemic congestion)
≤ 2.1 cm	< 50 % collapse	8 mmHg	5 – 10 mmHg	Intermediate RAP
> 2.1 cm	> 50 % collapse	8 mmHg	5 – 10 mmHg	Intermediate RAP (or athletic dilated IVC)

• PASP Calculation: Formula: PASP = 4 × (Peak TR Velocity)² + Estimated RAP.

• Ventilated / Athlete Caution: In young high-performance athletes or patients on positive pressure mechanical ventilation, IVC dilation without high RAP is common; clinical correlation and hepatic vein Doppler systolic flow reversal are mandatory.

6. THORACIC AORTA QUANTIFICATION

Aortic root dimensions are traditionally measured at end-diastole in the parasternal long-axis view using leading-edge to leading-edge (L-L) per ASE convention, or inner-edge to inner-edge (I-I) per 2021/2024 updated multimodal guidelines. Dimensions must be interpreted relative to age, sex, and BSA.

Aortic Landmark	Men Reference Range	Women Reference Range	Upper Normal Limit Indexed	Surgical Action Thresholds
Aortic Valve Annulus	20 – 31 mm	18 – 26 mm	13 – 19 mm/m²	Measured mid-systole inner-to-inner for TAVR/SAVR sizing.
Sinuses of Valsalva	31 – 40 mm (mean 34)	27 – 36 mm (mean 30)	≤ 21 mm/m²	≥ 50 mm in Marfan / BAV with risk factors; ≥ 55 mm in tricuspid AV.
Sinotubular Junction	26 – 34 mm	22 – 30 mm	≤ 18 mm/m²	Preservation of sinotubular waist is crucial in valve-sparing repair.
Ascending Aorta (Tubular)	27 – 38 mm	24 – 34 mm	≤ 21 mm/m²	≥ 50 mm in BAV with risk factors; ≥ 55 mm without risk factors.
Aortic Arch	22 – 36 mm	20 – 32 mm	≤ 18 mm/m²	Suprasternal notch view.

AORTIC RISK STRATIFICATION: Aortic size index (ASI = Aortic Diameter in cm / BSA in m²) > 2.75 cm/m² identifies patients at high risk of aortic dissection or rupture even when absolute diameter is < 5.5 cm.

7. AORTIC VALVE: STENOSIS & REGURGITATION

A. Aortic Stenosis (AS) Grading Criteria (ASE / EACVI)

Severity Parameter	Aortic Sclerosis	Mild AS	Moderate AS	Severe AS
Peak Velocity (Vmax) (m/s)	≤ 2.5 m/s	2.6 – 2.9 m/s	3.0 – 3.9 m/s	≥ 4.0 m/s
Mean Gradient (mmHg)	No gradient	< 20 mmHg	20 – 39 mmHg	≥ 40 mmHg
Aortic Valve Area (AVA) (cm²)	Normal	> 1.5 cm²	1.0 – 1.5 cm²	≤ 1.0 cm²
Indexed AVA (cm²/m²)	—	> 0.85 cm²/m²	0.60 – 0.85 cm²/m²	≤ 0.60 cm²/m²
Velocity Ratio (DVI = VTI_LVOT / VTI_AV)	—	> 0.50	0.25 – 0.50	< 0.25

B. Diagnostic Algorithm for Low-Flow, Low-Gradient Severe AS (AVA ≤ 1.0 cm², Mean Grad < 40 mmHg)

• Low-Flow Verification: Step 1: Check Stroke Volume Index (SVi). SVi < 35 mL/m² confirms true low-flow state.

• Classical LFLG AS (LVEF < 50%): Perform Low-Dose Dobutamine Stress Echo (up to 20 mcg/kg/min). If Flow Reserve present (SV increases ≥ 20%): (1) True Severe AS if Mean Gradient rises ≥ 40 mmHg and AVA remains ≤ 1.0 cm²; (2) Pseudo-Severe AS if AVA expands to > 1.0 cm² while gradient remains < 40 mmHg. If No Flow Reserve (SV fails to increase ≥ 20%), perform Non-Contrast Cardiac CT Calcium Score.

• Paradoxical LFLG AS (LVEF ≥ 50%): Rule out blood pressure elevation at exam time (causes systemic load overestimation). Perform Non-Contrast Cardiac CT Aortic Valve Calcium Scoring: Severe AS highly likely if Agatston score ≥ 2000 – 3000 AU in Men, and ≥ 1200 – 1600 AU in Women.

C. Aortic Regurgitation (AR) Grading Criteria

Echocardiographic Parameter	Mild AR	Moderate AR	Severe AR
Color Jet Width / LVOT Diameter	< 25 %	25 – 64 %	≥ 65 %
Vena Contracta Width (cm)	< 0.3 cm	0.3 – 0.6 cm	> 0.6 cm (or > 6 mm)
Pressure Half-Time (PHT) (ms)	> 500 ms	200 – 500 ms	< 200 ms
Holodiastolic Flow Reversal	Absent or brief early diastolic	Intermediate	Prominent holodiastolic (end-diastolic vel > 20 cm/s in desc. aorta)
Regurgitant Volume (RVol) (mL)	< 30 mL/beat	30 – 59 mL/beat	≥ 60 mL/beat
Regurgitant Fraction (RF) (%)	< 30 %	30 – 49 %	≥ 50 %
Effective Regurgitant Orifice Area (EROA)	< 0.10 cm²	0.10 – 0.29 cm²	≥ 0.30 cm²

ACUTE AR EMERGENCY PEARL: In acute severe AR (e.g. aortic dissection, infective endocarditis), the LV has not dilated yet, and PHT may be markedly shortened (< 200 ms) due to precipitous rise in LVEDP. Early mitral valve closure and premature opening of the aortic valve are hallmark emergency signs.

8. MITRAL VALVE: STENOSIS & REGURGITATION

A. Mitral Stenosis (MS) Grading Criteria

Diagnostic Parameter	Mild Mitral Stenosis	Moderate Mitral Stenosis	Severe Mitral Stenosis
Mean Transmitral Gradient (mmHg)	< 5 mmHg	5 – 10 mmHg	> 10 mmHg
Mitral Valve Area (MVA) (cm²)	> 1.5 cm²	1.0 – 1.5 cm²	≤ 1.0 cm² (ACC/AHA/ESC considers ≤ 1.5 cm² severe)
Pressure Half-Time (PHT) (ms)	< 150 ms	150 – 219 ms	≥ 220 ms (Formula: MVA = 220 / PHT)
Pulmonary Artery Systolic Pressure	< 30 mmHg	30 – 50 mmHg	> 50 mmHg (resting) / > 60 mmHg (exercise)

B. Wilkins Score (Total 4 to 16 points; Score ≤ 8 favors Percutaneous Balloon Mitral Valvotomy)

Score Point	Leaflet Mobility	Subvalvular Thickening	Leaflet Thickening	Valvular Calcification
1	Highly mobile, only leaflet tips restricted	Minimal thickening just below leaflet tips	Leaflets near normal (4-5 mm)	Single focal area of increased brightness
2	Mid and base portion have normal mobility	Thickening of chordae up to 1/3 chordal length	Mid-leaflets normal, thickening of margins (5-8 mm)	Scattered brightness confined to leaflet margins
3	Leaflet continues to move forward in diastole	Thickening extending to distal third of chordae	Thickening of entire leaflet (5-8 mm)	Brightness extending into mid portions of leaflets
4	No or minimal forward motion in diastole	Extensive chordal thickening and shortening to papillary muscle	Marked thickening of entire leaflet (> 8-10 mm)	Extensive brightness throughout much of the leaflet tissue

C. Mitral Regurgitation (MR) Grading Criteria (Primary vs Secondary MR)

Echocardiographic Parameter	Mild MR	Moderate MR	Severe Primary MR	Severe Secondary (Functional) MR
Structural Findings	Normal leaflet/apparatus	Moderate lesion	Flail leaflet, torn chordae, ruptured papillary	Severe regional LV remodeling, annular tethering
Vena Contracta Width (cm)	< 0.3 cm	0.3 – 0.69 cm	≥ 0.70 cm (≥ 7 mm)	≥ 0.70 cm (or multibeam > 8 mm)
PISA Radius at Nyquist 30-40 cm/s	< 0.4 cm	0.4 – 0.9 cm	≥ 1.0 cm	≥ 0.8 – 1.0 cm
Regurgitant Volume (RVol)	< 30 mL/beat	30 – 59 mL/beat	≥ 60 mL/beat	≥ 60 mL (or ≥ 30-45 mL in low flow)
Regurgitant Fraction (RF)	< 30 %	30 – 49 %	≥ 50 %	≥ 50 %
EROA (Effective Regurg. Orifice)	< 0.20 cm²	0.20 – 0.39 cm²	≥ 0.40 cm²	≥ 0.40 cm² (≥ 0.20 cm² carries adverse risk)
Pulmonary Vein Flow Doppler	Normal (S > D)	Systolic blunting (S < D)	Systolic Flow Reversal	Systolic Flow Reversal

SECONDARY MR PITFALL: In secondary/functional MR, the regurgitant orifice is often crescent-shaped and dynamic, leading to underestimation by 2D PISA. Multiplane 3D vena contracta area (3D VCA ≥ 0.41 cm²) or cardiac MRI is recommended in discordant cases.

9. TRICUSPID VALVE: STENOSIS & REGURGITATION

A. Tricuspid Stenosis (TS)

• Severe Cutoff: Mean Inflow Pressure Gradient: Severe TS is defined by Mean Gradient ≥ 5 mmHg (at normal heart rate).

• Ancillary Findings: Inflow VTI > 60 cm; Tricuspid Valve Area ≤ 1.0 cm²; Pressure Half-Time (PHT) ≥ 190 ms (TVA = 190 / PHT).

B. Tricuspid Regurgitation (TR): Contemporary 5-Grade Staging System

The ASE and modern transcatheter interventional guidelines expand severe TR into Severe, Massive, and Torrential grades to risk-stratify therapy:

TR Severity Grade	Vena Contracta Width (mm)	EROA by PISA (mm²)	Regurgitant Volume (mL)	Hepatic Vein Doppler Flow
Mild TR	< 3.0 mm	< 20 mm²	< 30 mL	Systolic dominant flow
Moderate TR	3.0 – 6.9 mm	20 – 39 mm²	30 – 44 mL	Systolic blunting (S < D)
Severe TR	7.0 – 13.9 mm	40 – 59 mm²	45 – 59 mL	Systolic flow reversal
Massive TR	14.0 – 20.9 mm	60 – 79 mm²	60 – 74 mL	Prominent holosystolic flow reversal
Torrential TR	≥ 21.0 mm	≥ 80 mm²	≥ 75 mL	Torrential holosystolic reversal, large coaptation gap

TORRENTIAL TR VELOCITY TRAP: Severe TR leads to hepatic congestion, renal dysfunction, and RV volume overload. In torrential TR, the CW Doppler TR spectral profile shows an early-peaking triangular contour ('cutoff sign') with low peak velocity (< 2.0 m/s) due to rapid ventricular-atrial pressure equalization, which may paradoxically cause underestimation of RVSP!

10. PULMONIC VALVE: STENOSIS & REGURGITATION

A. Pulmonic Stenosis (PS) Grading Criteria

Severity Category	Peak Transvalvular Velocity (m/s)	Peak Systolic Gradient (mmHg)	Clinical Recommendation
Mild Pulmonic Stenosis	< 3.0 m/s	< 36 mmHg	Routine surveillance; intervention not required.
Moderate Pulmonic Stenosis	3.0 – 4.0 m/s	36 – 64 mmHg	Close surveillance; assess RV hypertrophy and dimensions.
Severe Pulmonic Stenosis	> 4.0 m/s	> 64 mmHg	Class I indication for percutaneous balloon pulmonary valvuloplasty.

B. Pulmonic Regurgitation (PR) & Pulmonary Artery Pressure Estimation

• Severe PR Criterion 1: Color Doppler PR jet width occupying > 65% of the pulmonary valve annulus / RVOT.

• Severe PR Criterion 2: Dense, steep continuous-wave PR Doppler spectral tracing with rapid deceleration and Pressure Half-Time (PHT) < 100 ms.

• Severe PR Criterion 3: Premature termination of diastolic PR flow before end-diastole (diastolic equalization of PA and RV pressures).

• Mean Pulmonary Artery Pressure: Formula: Mean PAP = 4 × (Early/Peak PR Velocity)² + RAP (Normal < 20 mmHg; Pulmonary HTN ≥ 20 mmHg).

• Pulmonary Artery Diastolic Pressure: Formula: PADP = 4 × (End-Diastolic PR Velocity)² + RAP (Normal < 12-15 mmHg).

11. PROSTHETIC VALVES: NORMAL RANGES, PPM & DYSFUNCTION

A comprehensive baseline echocardiogram should be performed 4 to 6 weeks post-implantation. Every prosthetic valve examination must report: peak velocity, mean pressure gradient, Doppler Velocity Index (DVI), and Effective Orifice Area (EOA) by continuity equation.

A. Doppler Hemodynamic Ranges for Normally Functioning Prostheses

Prosthetic Valve Type / Position	Peak Velocity (m/s)	Mean Gradient (mmHg)	DVI / Velocity Ratio	Effective Orifice Area (EOA)	PHT (ms)
Prosthetic Aortic Valve (SAVR / TAVR)	< 3.0 m/s	< 20 mmHg	≥ 0.30	> 1.2 cm²	—
Possible Aortic Prosthesis Obstruction	≥ 3.0 m/s	≥ 20 mmHg	< 0.25 – 0.30	≤ 1.2 cm²	AT > 100 ms (AT/ET > 0.35)
Definite Aortic Prosthesis Obstruction	> 4.0 m/s	≥ 35 mmHg	< 0.25	≤ 0.8 cm²	AT > 100 ms (AT/ET > 0.37)
Prosthetic Mitral Valve (Mechanical)	< 1.9 m/s	≤ 5.0 mmHg	< 2.2 (PrMV/LVOT)	≥ 1.5 cm²	< 130 ms
Prosthetic Mitral Valve (Bioprosthetic)	< 2.0 m/s	≤ 6.0 mmHg	< 2.2 (PrMV/LVOT)	≥ 1.5 cm²	< 130 ms
Possible Mitral Prosthesis Obstruction	≥ 2.0 m/s	6 – 10 mmHg	2.2 – 2.5	1.0 – 1.4 cm²	130 – 200 ms
Definite Mitral Prosthesis Obstruction	≥ 2.5 m/s	> 10 mmHg	> 2.5	< 1.0 cm²	> 200 ms

B. Prosthesis-Patient Mismatch (PPM) Classification

PPM occurs when the prosthetic effective orifice area is too small relative to the patient's body surface area despite normal mechanical leaflet motion:

Position / Patient Cohort	No Mismatch (Normal)	Moderate PPM	Severe PPM
Aortic Prosthesis (Non-Obese, BMI < 30)	> 0.85 cm²/m²	0.66 – 0.85 cm²/m²	≤ 0.65 cm²/m²
Aortic Prosthesis (Obese, BMI ≥ 30)	> 0.70 cm²/m²	0.56 – 0.70 cm²/m²	≤ 0.55 cm²/m²
Mitral Prosthesis (All patients)	> 1.20 cm²/m²	0.90 – 1.20 cm²/m²	≤ 0.90 cm²/m²

C. Distinguishing Prosthetic Dysfunction: PPM vs Pathologic Obstruction vs Regurgitation

Feature / Finding	Prosthesis-Patient Mismatch (PPM)	Prosthetic Stenosis (Pannus / Thrombus)	Significant Regurgitation (Paravalvular / Intra)
Prosthetic Valve EOA	Small (≤ 0.65 cm²/m² indexed)	Small (< 0.8 cm² absolute)	Normal or increased
Doppler Velocity Index (DVI)	NORMAL (≥ 0.30 aortic)	REDUCED (< 0.25 aortic; > 2.5 mitral)	NORMAL or mildly elevated
Acceleration Time (AT)	< 80 ms (Normal contour)	PROLONGED (> 100 ms; rounded contour)	< 80 ms (Early peaking triangular)
AT / Ejection Time (ET) Ratio	< 0.30	≥ 0.37	< 0.30
Leaflet / Occluder Motion	Normal opening & closing	Restricted or absent excursion	Hyperdynamic flow / paravalvular jet
Historical Comparison	Present immediately post-op	Progressive worsening over months/years	Acute drop in BP or new murmur

12. ESSENTIAL FORMULAS & CLINICAL CALCULATION CHEAT SHEET

Formula Name	Mathematical Equation	Standard Cutoff / Clinical Target
Continuity Equation (Aortic Valve Area)	AVA = (CSALVOT × VTILVOT) / VTIAV = [0.785 × (D_LVOT)² × VTILVOT] / VTIAV	Severe AS if AVA ≤ 1.0 cm² (or ≤ 0.6 cm²/m²)
Doppler Velocity Index (DVI - Aortic)	DVI = VTILVOT / VTIAV (or Vmax_LVOT / Vmax_AV)	Severe AS if DVI < 0.25 (independent of LVOT diameter)
Mitral Valve Area (PHT method)	MVA = 220 / Pressure Half-Time (ms)	Severe MS if PHT ≥ 220 ms (MVA ≤ 1.0 cm²)
PISA Method: Regurgitant Flow Rate	Flow Rate = 2 × π × r² × Valias = 6.28 × r² × Valias	Standard alias velocity set to 30 – 40 cm/s
PISA Method: EROA	EROA = Regurgitant Flow Rate / Peak Vreg	Severe Primary MR if EROA ≥ 0.40 cm² (Severe TR ≥ 40 mm²)
PISA Method: Regurgitant Volume (RVol)	RVol = EROA × VTIreg (or Flow Rate × [VTIreg / Vreg])	Severe MR if RVol ≥ 60 mL/beat
Modified Bernoulli Equation	ΔP = 4 × (Velocity)²	Calculates peak instantaneous transvalvular gradient
Pulmonary Artery Systolic Pressure (PASP)	PASP = 4 × (TR Vmax)² + Estimated RAP	Normal resting PASP ≤ 35 mmHg; PH > 35 mmHg
Pulmonary Vascular Resistance (PVR - Echo)	PVR (Wood Units) = 10 × [TR Vmax (m/s) / VTILVOT (cm)] + 0.22	Normal PVR < 2 Wood Units; Elevated > 3 WU
Relative Wall Thickness (RWT)	RWT = (2 × LVPWd) / LVIDd	Concentric pattern if RWT > 0.42; Eccentric if ≤ 0.42
RV Fractional Area Change (FAC)	FAC (%) = [(RV End-Diastolic Area – RV End-Systolic Area) / EDA] × 100	Abnormal RV systolic function if FAC < 35 %
Shunt Ratio (Qp : Qs)	Qp/Qs = (CSARVOT × VTIRVOT) / (CSALVOT × VTILVOT)	Significant left-to-right shunt if Qp:Qs > 1.5

CRITICAL LVOT MEASUREMENT WARNING: Always confirm accurate LVOT diameter measurement (measured in mid-systole from inner-edge to inner-edge at the base of aortic valve cusps, 3-5 mm below the annulus). Because the diameter is squared in the continuity equation, a 10% error in LVOT diameter produces a 21% error in stroke volume and aortic valve area!